JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ERF
3451
DELISTED
Enerplus Corporation
ERF
| $1.81M | ﹤0.01% |
125,742
+33,784
| +37% | +$544K |
2015 Q3
30 quarters
|
|
3452
MakeMyTrip
MMYT
$3.98B
| $1.81M | ﹤0.01% |
73,974
+1,385
| +2% | +$36.8K |
2021 Q3
6 quarters
|
|
3453
PUT
Western Union
WU
$1.89B
| $1.8M | ﹤0.01% |
161,700
+60,100
| +59% | +$782K |
2022 Q4
1 quarter
|
|
3454
Invesco S&P SmallCap Health Care ETF
PSCH
$177M
| $1.8M | ﹤0.01% |
41,244
+1,434
| +4% | +$64.8K |
2021 Q1
8 quarters
|
|
3455
Provident Financial Services
PFS
$2.85B
| $1.8M | ﹤0.01% |
93,678
+17,533
| +23% | +$388K |
2013 Q2
39 quarters
|
|
3456
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
$9.68B
| $1.8M | ﹤0.01% |
76,154
+13,522
| +22% | +$319K |
2022 Q4
1 quarter
|
|
|
THR
3457
DELISTED
Thermon Group Holdings
THR
| $1.8M | ﹤0.01% |
72,072
+30,199
| +72% | +$737K |
2017 Q4
21 quarters
|
|
|
GTLS.PRB
3458
DELISTED
Chart Industries 6.75% Series B Preferred Stock
GTLS.PRB
| $1.79M | ﹤0.01% |
33,500
-25,900
| -44% | -$1.41M |
2022 Q4
1 quarter
|
|
|
DO
3459
DELISTED
Diamond Offshore Drilling, Inc.
DO
| $1.79M | ﹤0.01% |
148,835
+44,126
| +42% | +$507K |
2022 Q2
3 quarters
|
|
|
RYZ
3460
Ryerson Holding Corp
RYZ
$1.34B
| $1.78M | ﹤0.01% |
48,834
-36,346
| -43% | -$1.32M |
2016 Q1
28 quarters
|
|
3461
Live Oak Bancshares
LOB
$1.59B
| $1.77M | ﹤0.01% |
72,757
+18,645
| +34% | +$585K |
2017 Q3
22 quarters
|
|
|
TRHC
3462
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $1.77M | ﹤0.01% |
316,937
+208,664
| +193% | +$1.19M |
2017 Q3
22 quarters
|
|
3463
Capital Group Dividend Value ETF
CGDV
$38.9B
| $1.77M | ﹤0.01% |
+71,034
| New | +$1.74M |
2023 Q1
0 quarters
|
|
3464
Harmony Biosciences
HRMY
$2.3B
| $1.77M | ﹤0.01% |
54,194
-38,611
| -42% | -$1.76M |
2020 Q3
10 quarters
|
|
3465
Mercantile Bank Corp
MBWM
$999M
| $1.77M | ﹤0.01% |
57,768
-2,680
| -4% | -$89.8K |
2016 Q2
27 quarters
|
|
3466
First Trust Rising Dividend Achievers ETF
RDVY
$25B
| $1.76M | ﹤0.01% |
39,247
+10,670
| +37% | +$490K |
2017 Q3
22 quarters
|
|
3467
CALL
Devon Energy
DVN
$52.6B
| $1.76M | ﹤0.01% |
34,800
+26,000
| +295% | +$1.48M |
2021 Q4
5 quarters
|
|
3468
RXO
RXO
$4.68B
| $1.76M | ﹤0.01% |
89,563
-42,902
| -32% | -$823K |
2022 Q4
1 quarter
|
|
3469
Nuveen ESG Small-Cap ETF
NUSC
$1.23B
| $1.76M | ﹤0.01% |
49,543
+3,779
| +8% | +$137K |
2022 Q3
2 quarters
|
|
3470
CEVA Inc
CEVA
$1.01B
| $1.75M | ﹤0.01% |
57,670
+11,491
| +25% | +$360K |
2016 Q3
26 quarters
|
|
3471
WisdomTree US SmallCap Dividend Fund
DES
$2.05B
| $1.75M | ﹤0.01% |
61,467
+21,187
| +53% | +$634K |
2013 Q2
39 quarters
|
|
|
HRT
3472
DELISTED
HireRight Holdings Corporation
HRT
| $1.75M | ﹤0.01% |
165,370
+104,282
| +171% | +$1.17M |
2021 Q4
5 quarters
|
|
|
FITB
3473
CALL
Fifth Third Bancorp
FITB
$45.4B
| $1.75M | ﹤0.01% |
65,700
+29,300
| +80% | +$974K |
2022 Q4
1 quarter
|
|
|
ARR
3474
Armour Residential REIT
ARR
$1.88B
| $1.74M | ﹤0.01% |
66,337
+37,707
| +132% | +$1.07M |
2015 Q3
30 quarters
|
|
|
FPI
3475
Farmland Partners
FPI
$456M
| $1.74M | ﹤0.01% |
162,769
-51,117
| -24% | -$598K |
2016 Q1
28 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.